These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19272494)

  • 1. Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature.
    Bachmann G; Korner P
    Contraception; 2009 Apr; 79(4):247-58. PubMed ID: 19272494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding patterns associated with oral contraceptive use: a review of the literature.
    Bachmann G; Korner P
    Contraception; 2007 Sep; 76(3):182-9. PubMed ID: 17707714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
    Westhoff C; Osborne LM; Schafer JE; Morroni C
    Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal rings for contraception: endocrine parameters.
    Olsson SE
    Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
    Máximo MM; Silva PS; Vieira CS; Gonçalvez TM; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA; Poli-Neto OB
    Fertil Steril; 2015 Nov; 104(5):1182-9. PubMed ID: 26341277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovations in contraception: a review.
    Zurawin RK; Ayensu-Coker L
    Clin Obstet Gynecol; 2007 Jun; 50(2):425-39. PubMed ID: 17513928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives].
    Gompel A
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S356-64. PubMed ID: 19268214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Backman T; Rauramo I; Jaakkola K; Inki P; Vaahtera K; Launonen A; Koskenvuo M
    Obstet Gynecol; 2005 Oct; 106(4):813-7. PubMed ID: 16199640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive vaginal rings.
    Harwood B; Mishell DR
    Semin Reprod Med; 2001 Dec; 19(4):381-90. PubMed ID: 11727180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of contraceptive vaginal rings].
    Elstein M; Jackson R; Hickling D; Assendorp R
    Contracept Fertil Sex (Paris); 1992 Jan; 20(1):15-9. PubMed ID: 12343624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal uterine bleeding associated with hormonal contraception.
    Schrager S
    Am Fam Physician; 2002 May; 65(10):2073-80. PubMed ID: 12046776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.
    Murphy PA; Brixner D
    Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogen-only contraception: a review.
    Gupta S
    Practitioner; 2005 Feb; 249(1667):90, 93-4, 96 passim. PubMed ID: 15724528
    [No Abstract]   [Full Text] [Related]  

  • 18. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in hormone delivery systems.
    Shulman LP; Nelson AL; Darney PD
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S39-48. PubMed ID: 15105797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of progestins in contraception.
    Erkkola R; Landgren BM
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):207-16. PubMed ID: 15715527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.